Literature DB >> 2982214

Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans.

J M Hoeg, S J Demosky, R E Gregg, E J Schaefer, H B Brewer.   

Abstract

Since the liver is a central organ for lipid and lipoprotein synthesis and catabolism, hepatic receptors for specific apolipoproteins on plasma lipoproteins would be expected to modulate lipid and lipoprotein metabolism. The role of hepatic receptors for low density lipoproteins and apolipoprotein E-containing lipoproteins was evaluated in patients with complementary disorders in lipoprotein metabolism: abetalipoproteinemia and homozygous familial hypercholesterolemia. In addition, hepatic membranes from a patient with familial hypercholesterolemia were studied and compared before and after portacaval shunt surgery. The results establish that the human liver has receptors for apolipoproteins B and E. Furthermore, in the human, hepatic receptors for low density lipoproteins and apolipoprotein E are genetically distinct and can undergo independent control.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982214     DOI: 10.1126/science.2982214

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.

Authors:  M C van Dijk; G J Ziere; W Boers; C Linthorst; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia.

Authors:  J M Hoeg; T E Starzl; H B Brewer
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

3.  Lipoprotein binding to cultured human hepatoma cells.

Authors:  F Krempler; G M Kostner; W Friedl; B Paulweber; H Bauer; F Sandhofer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

Review 4.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

5.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

Authors:  U Beisiegel; W Weber; G Bengtsson-Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Familial apolipoprotein E deficiency.

Authors:  E J Schaefer; R E Gregg; G Ghiselli; T M Forte; J M Ordovas; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

7.  Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects.

Authors:  J M Hoeg; S B Edge; S J Demosky; T E Starzl; T Triche; R E Gregg; H B Brewer
Journal:  Biochim Biophys Acta       Date:  1986-05-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.